Bio-Techne (TECH) Cost of Revenue (2009 - 2026)

Bio-Techne's Cost of Revenue history runs 18 years deep, the most recent figure standing at $103.1 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 1.48% year-over-year to $103.1 million; the TTM figure through Mar 2026 stood at $424.3 million (up 2.5% YoY), while the FY2025 annual figure was $429.4 million, up 10.28% from the prior year.
• Cost of Revenue was $103.1 million for Q1 2026 at Bio-Techne, down from $104.6 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $118.2 million in Q2 2025 to a low of $87.9 million in Q2 2022.
• Historically, Cost of Revenue has averaged $98.2 million across 5 years, with a median of $98.4 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue rose 18.12% in 2022, then declined 7.51% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $88.2 million in 2022, then rose by 8.83% to $96.0 million in 2023, then grew by 7.43% to $103.1 million in 2024, then rose by 1.41% to $104.6 million in 2025, then slipped by 1.41% to $103.1 million in 2026.
• The last three Cost of Revenue figures came in at $103.1 million (Q1 2026), $104.6 million (Q4 2025), and $98.4 million (Q3 2025), per Business Quant data.